National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information
 Employee Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Prevention Sciences Program (PSP)

The development of new and more effective non-vaccine methods and strategies to prevent HIV infection is an important component of NIAID’s HIV research agenda. Within NIAID, the Division of AIDS supports research on biomedical and behavioral prevention approaches through the Prevention Sciences Program (PSP), which includes the Microbicide Research Branch and the Prevention Research Branch, that carries out the following activities:

  • Oversees grants, contracts, and cooperative agreements that support preclinical and clinical prevention research, including the HIV Prevention Trials Network (HPTN) and Microbicide Trials Network (MTN)
  • Promotes research programs to discover non-vaccine prevention strategies
  • Coordinates research activities in consultation and/or collaboration with other government agencies, international organizations, and other Institutes at the National Institutes of Health.
  • Works with the pharmaceutical industry and the Food and Drug Administration to facilitate the evaluation and approval of new prevention strategies
  • Provides scientific guidance to grantees and contractors

For more information about NIAID’s HIV prevention research efforts, visit the HIV/AIDS Prevention Science Research Area.

back to top


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
Sept. 25, 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Sept. 24, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS



    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
    Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
    Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
    Sept. 25, 2009

    HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
    Sept. 24, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS